XML 25 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Note 4 - Earnings Per Common Share
3 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 4 - EARNINGS PER COMMON SHARE

 

The following table presents the amounts used to compute basic and diluted earnings per common share, as well as the effect of dilutive potential common shares on weighted average shares outstanding (in thousands, except per share data):

 

   

Three Months Ended

 
   

September 30

 
   

2023

   

2022

 
                 
BASIC EARNINGS PER SHARE                
                 

Net income

  $ 8,028     $ 6,262  
                 

Weighted average shares outstanding during the period, net of treasury shares

    27,738       26,730  

Weighted average vested restricted stock units outstanding

    82       46  

Weighted average shares outstanding in the Deferred Compensation Plan during the period

    937       865  

Weighted average shares outstanding

    28,757       27,641  
                 

Basic earnings per common share

  $ 0.28     $ 0.23  
                 
                 

DILUTED EARNINGS PER SHARE

               
                 

Net income

  $ 8,028     $ 6,262  
                 

Weighted average shares outstanding:

               
                 

Basic

    28,757       27,641  
                 

Effect of dilutive securities (a):

               

Impact of common shares to be issued under stock option plans, and contingently issuable shares, if any

    1,198       1,023  

Weighted average shares outstanding

    29,955       28,664  
                 

Diluted earnings per common share

  $ 0.27     $ 0.22  
                 

Anti-dilutive securities (b)

    -       213  

 

 

(a)

Calculated using the “Treasury Stock” method as if dilutive securities were exercised and the funds were used to purchase common shares at the average market price during the period.

 

 

(b)

Anti-dilutive securities were excluded from the computation of diluted net income per share for the three months ended September 30, 2023, and September 30, 2022, because the exercise price was greater than the average fair market price of the common shares or because the assumed proceeds from the award’s exercise or vesting was greater than the average fair market price of the common shares.